Back to Man Group plc

REGN
Showing 8 of 30 quarters

Position history for Man Group plc's holdings in REGENERON PHARMACEUTICALS

Man Group plc holds 315,212 shares of REGN (REGENERON PHARMACEUTICALS), worth $243.5M as of 2026-Q1. The position was increased (+44.5% shares). REGN represents 0.4% of Man Group plc's portfolio.

Current Value

$243.5M

Current Shares

315,212

Total Value Change

+$189.2M

Total Shares Change

+263,468

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
315,212
+44.5%
$243.5M0.4%$766.66
50
2025-Q4
Decreased
218,112
-19.7%
$168.4M0.3%$773.94
0
2025-Q3
Increased
271,707
+257.6%
$152.8M0.3%$560.05
58
2025-Q2
Increased
75,983
+113.5%
$39.9M0.1%$519.56
47
2025-Q1
Decreased
35,586
-1.5%
$22.6M0.1%$634.66
0
2024-Q4
Decreased
36,144
-40.3%
$25.7M0.1%$698.71
0
2024-Q3
Increased
60,521
+17.0%
$63.6M0.2%$1,036.94
41
2024-Q2
Decreased
51,744
-52.3%
$54.4M0.1%$1,045.23
0

Other major holders of REGN: VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used